Navigation Links
MedWaves, Inc. Sponsors Investigational Studies to Evaluate Its Patented Microwave Thermal Coagulation-Ablation System for Treatment of Tumors in Liver and Lung
Date:9/18/2009

.jpg

Multiple AveCure(TM) systems can concurrently apply energy to treat larger lesions or shape the ablation zone to fit lesion boundaries. Image-2 below shows a liver lesion (70mm x 70mm x 90mm) ablation zone created by using three AveCure(TM) probes. The top left image is pre-ablation; top center and top right images are during ablation; bottom three images are post-ablation.

Image 2:http://www.ereleases.com/pr/2009-MedWaves-Image-2.jpg

PDF File of Release with Images:http://www.ereleases.com/pr/2009-MedWaves-News-Release.pdf

Post-ablation images show significant shrinkage in the liver tissue ablation zone. The AveCure(TM) probe of the same type percutaneously ablated a kidney cyst as well. MedWaves' proprietary microwave technology delivers predictable ablation performance not seen in other microwave and radiofrequency systems in the market, and shows its versatility. Additional benefits of microwave ablation are less pain and discomfort during percutaneous outpatient procedures, and clinical cases have shown to significantly reduce anesthetic dosage requirements when compared to radiofrequency ablation. The reduced anesthetic requirement could allow the physicians to treat larger populations of patients. Innovation continues at MedWaves. The company is developing smaller diameter microwave probes/antennae with focused microwave fields to destroy small metastatic lesions in liver, lung and other organs safely and effectively.

The energy-based therapy generates sales of $25 billion worldwide and growing at 11% per annum. Current worldwide tumor ablation generates sales of $250 million and growing at 25%-30% per annum. This accounts for only 5% m
'/>"/>

SOURCE MedWaves, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. MedWaves, Inc. Announces Receipt of United States Food and Drug Administration 510k Clearance to Market Its Patented Microwave Coagulation/Ablation System
2. MedWaves, Inc. Announces Receipt of MDD CE Certification and Additional U.S. FDA 510(k) Clearance to Market Its Patented Microwave Coagulation/Ablation System and Devices
3. TriWest Sponsors Congressional Medal of Honor Convention
4. PowerBar Issues Open Call for 2008-2009 PowerBar Team Elite(TM) Athlete Sponsorship Program
5. Morris Animal Foundation 2008 Sponsorship Guide Available, Details Current Animal Health Studies
6. Energizer Joins Roster of Susan G. Komen Race for the Cure(R) National Sponsors; Energizer(R) ReTreat Pampers Cancer Survivors With Traveling Mini-Spa
7. Volkswagen Continues Sponsorship of the Lasalle Bank Chicago Marathon
8. XYIENCE(R) Announces $12 Million Funding and Signing of Long Term UFC(R) Sponsorship
9. Inovis Sponsors ASC X12 Conference, Exhibits BizManager and Secure Link
10. D.I.S.C. Scores First Sponsorship Deal as Official Medical Center of the Los Angeles Kings
11. Food and Drug Law Institute Sponsors Colloquium on Communicating Risk/Safety Drug Information
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... ... June 29, 2015 , ... Mediaplanet has released the ... USA TODAY. This 12-page, glossy, full-color special section hit newsstands Friday, June 26th, ... totaling approximately 450,000 copies, with an estimated readership of 1.3 million. The digital ...
(Date:6/29/2015)... ... June 29, 2015 , ... Brittenford Systems, a provider ... other growing businesses across the United States, has announced that it has been ... fifth consecutive year. , Based on company revenue and number of employees, Bob ...
(Date:6/29/2015)... , ... June 29, 2015 , ... ... developed a new approach to build nearly complete genomes by combining high-throughput DNA ... genomic variation, critically important for their association with human disease, but previously difficult ...
(Date:6/29/2015)... (PRWEB) , ... June 29, 2015 , ... San ... to lift and tighten sagging skin. Ulthera is a special treatment that offers a ... uses ultrasound technology to gently stimulate collagen production. Ulthera is highly targeted and precise ...
(Date:6/29/2015)... ... June 29, 2015 , ... ... Biology and Chemical Technology of The Hong Kong Polytechnic University (PolyU) has developed ... oils. Authentication of edible oils has been a long-term issue in food safety, ...
Breaking Medicine News(10 mins):Health News:Mediaplanet partners with USA TODAY and Kris Letang to raise awareness about the risk of heart attack and stroke 2Health News:Brittenford Systems Celebrates Fifth Consecutive Year on Bob Scott Insights Top 100 VARs 2Health News:Brittenford Systems Celebrates Fifth Consecutive Year on Bob Scott Insights Top 100 VARs 3Health News:Mount Sinai Scientists Develop New Approach for More Accurate and Comprehensive Whole Genome Assembly, Variant Discovery and Interpretation 2Health News:Mount Sinai Scientists Develop New Approach for More Accurate and Comprehensive Whole Genome Assembly, Variant Discovery and Interpretation 3Health News:Mount Sinai Scientists Develop New Approach for More Accurate and Comprehensive Whole Genome Assembly, Variant Discovery and Interpretation 4Health News:Dermatologist, Dr. Peyman Ghasri, is Now Offering Non-Invasive Skin Tightening Procedures 2Health News:Dermatologist, Dr. Peyman Ghasri, is Now Offering Non-Invasive Skin Tightening Procedures 3Health News:PolyU develops a new method for rapid authentication of edible oils and screening of gutter oils 2
... mammograms are more likely to interpret a benign growth ... and experience," and CAD systems do not help detect ... systems use complex algorithms to identify "suspicious" areas of ... which cost $50,000 to $175,000, were approved by FDA ...
... were the biggest killers. Now it appears that the ravage ... the fatalities caused by road accidents. , ... of Edinburgh, has provided statistics which demonstrates the increase in ... in contrast, MRSA cases had dropped by 4.3 per cent. ...
... University, has found a mutation in a single gene that ... among dog breeds and probably is important in determining the ... the April 6 issue of the journal Science, "is one ... dog breeds that share the same trait (such as large ...
... nations is undermining essential health services, including treatments for ... Margaret Chan said on Tuesday in Singapore ahead of ... of health care professionals have left their homes in ... wealthier countries, Reuters reports. ,According to WHO's ...
... African nation and very poor, has banned the life-threatening practice ... ,Anybody involved in female genital mutilation (FGM) would ... ,The move follows a campaign against the practice ... than 90% of Eritrean women are circumcised. ...
... and routine walks could ease uncomfortable symptoms and help women ... ,Menopause is the time in a woman's life when ... occurs naturally, most often after age 45. ... the health of more than 160 women, dividing them into ...
Cached Medicine News:Health News:Researchers Identify Gene That Plays Key Role in Size of Dogs -- and Probably in Humans 2Health News:Eritrea Bans Female Circumcision 2
(Date:6/29/2015)... SAN FRANCISCO , June 29, ... company,s novel blood-draw technology has received CE Mark ... quality from the European Union. This regulatory milestone ... alternative to one of the most common procedures ... Velano Vascular,s proprietary device reduces the ...
(Date:6/29/2015)... , June 29, 2015 ... and predicted revenues ,Where is the market for dermatological ... market? Visiongain ,s new report shows you potential ... and prospects. Our 310 page report ... most lucrative areas in the industry and the future ...
(Date:6/29/2015)... Calif. , June 29, 2015  The ... innovative features to cars on the basis of ... The industry is now on the verge of ... cars. While automotive HWW non-critical features such as ... be present in 30 to 40 percent of ...
Breaking Medicine Technology:Velano Vascular Receives CE Mark For Novel Blood Draw Technology Designed to Reduce Needle Exposures for Hospitalized Patients and Healthcare Providers 2Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 2Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 3Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 4Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 5Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 6Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 7Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 8Convergence Trends See the Automotive Industry Integrate Health, Wellness and Wellbeing into Vehicles 2Convergence Trends See the Automotive Industry Integrate Health, Wellness and Wellbeing into Vehicles 3Convergence Trends See the Automotive Industry Integrate Health, Wellness and Wellbeing into Vehicles 4
... Expected in November 2008, BOTHELL, Wash., Oct. 9 ... the completion of patient enrollment and dosing,for the third ... and,efficacy of its formulation of 12-hour extended-release (ER) ibuprofen ... top-line,results from this pivotal trial in November 2008. Ibuprofen ...
... Will Reduce Animal Use in Cosmetics and Chemicals ... Corp. today announced,that results of a recently completed ... EpiDerm in vitro human skin tissue,equivalent. The test ... to be accepted as a validated alternative to ...
Cached Medicine Technology:SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3MatTek's EpiDerm In Vitro Tissues Headed for Validation in Europe 2
... A concentrated enzymatic cleanser ... semi-automated hematology instruments. It ... all Abbott CELL-DYN® hematology ... instruments. The shelf life ...
Streck-CD3500 Hemoglobin/Lyse is a lytic reagent for the quantitative determination of hemoglobin on the Abbott CELL-DYN® 3500 and 3700. The shelf life is two years from the date of manufacture....
Streck-Diluent III Plus is a balanced electrolyte solution manufactured specifically for use as a diluent for blood cell counting and sizing on the Abbott CELL-DYN® 3000, 3500 and 3700. The shelf...
Streck-Diluent IIIA is a balanced electrolyte solution manufactured specifically for use as a diluent for blood cell counting and sizing on the Abbott CELL-DYN® 1700. The shelf life is one year f...
Medicine Products: